Nina Urke Ertesvåg's picture

Nina Urke Ertesvåg

Guest Researcher
  • E-mailnina.ertesvag@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2023). Post COVID-19 condition after delta infection and omicron reinfection in children and adolescents. EBioMedicine. 10 pages.
  • Show author(s) (2023). Durable immune responses after BNT162b2 vaccination in home-dwelling old adults. Vaccine: X. 1-11.
  • Show author(s) (2022). Seasonal influenza vaccination expands hemagglutinin-specific antibody breadth to older and future A/H3N2 viruses. npj Vaccines. 10 pages.
  • Show author(s) (2022). Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment. Viruses.
  • Show author(s) (2022). A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern. Communications Medicine. 11 pages.
Popular scientific article
  • Show author(s) (2020). Vaksinen si historie. . Naturen.
  • Show author(s) (2020). Kva skjer med vaksinen i kroppen. . Naturen.
  • Show author(s) (2020). COVID-19 og jakta på ein vaksine. Naturen.
Feature article
  • Show author(s) (2018). Få en influensafri jul! Bergens Tidende.
  • Show author(s) (2019). Seasonal influenza vaccination induces broad antibody responses against antigenically distinct A/H3N2 viruses.
  • Show author(s) (2019). Seasonal Influenza Vaccination Induces Cross-Reactive Antibodies Against A/H3N2 Viruses.

More information in national current research information system (CRIStin)